Blogs and News
Discover our latest news and blog articles, dedicated to demystifying drug development, medicine, clinical research, and ethics.
Clinical trials are unique, each with their own protocol, parameters, participants and therapeutic areas. They can differ greatly, covering a range of treatment and study types, and subject to different local regulations and cultural factors. So how do you know what defines success?
As the COVID-19 pandemic continues, day after day we are inundated with information. For the CRO industry, the message is that measures are in place and everything is under control; remote meeting and monitoring capabilities are keeping trials ticking over. This is true, but it’s only part of the story. In reality, remote monitoring is limited, as CRAs do not have access to source documents.
This will leave a backlog in monitoring that will have a significant impact when we reach the ‘new normal’. Everyone should be prepared, not just for this inevitable backlog, but also for the studies you have planned for the future.
Managing Your Clinical Trial During COVID-19: Siron Clinical Can Help You Navigate Through Uncertain Times
I would like to begin by saying I hope you and your family are staying safe and healthy during this uncertain time. I know the COVID-19 pandemic is having an impact, both professionally and personally, on everyone.
Clinical trials come with vast amounts of information, and a new partnership between Siron Clinical and Montrium will ensure clients benefit from efficient and effective trial information management in an increasingly digitized clinical research industry.
Siron Clinical is very happy to welcome Maja Armitrage to our team. Maja brings her considerable experience in clinical trial management to Siron Clinical. We sat down with her recently to talk about her skills, her achievements, and what she plans to bring to Siron Clinical.
An estimated 1 in 50 children over the age of 4 are allergic to peanuts; a new immunotherapy now approved by the FDA, following phase III trials carried out with support from Siron Clinical, will help increase their tolerance to peanuts and reduce their risk of anaphylaxis.